Patents by Inventor Lingli Zhou

Lingli Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250017136
    Abstract: Provided is a cultivation method for increasing yield of ratooning rice and reducing Cd content and use thereof, belonging to the technical field of agricultural planting. The cultivation method for increasing yield of ratooning rice and reducing Cd content comprises sowing seeds of ratooning rice in middle and late March of a year, conducting transplantation in middle April of the year for growth in a Cd-contaminated rice field, performing water and fertilizer management of a first season rice, harvesting the first season rice at a position between 1st and 2nd last nodes thereof and performing water and fertilizer management of a second season rice. The cultivation method provided by the present disclosure may significantly increase the yield of ratooning rice, significantly reduce the content of Cd in brown rice of ratooning rice season, and is of great significance for the safe utilization of contaminated farmland.
    Type: Application
    Filed: May 23, 2022
    Publication date: January 16, 2025
    Applicants: INSTITUTE OF SOIL SCIENCE, CHINESE ACADEMY OF SCIENCES, JIANGXI JIEDI ENVIRONMENTAL TREATMENT & ECOLOGICAL TECHNOLOGY CO., LTD
    Inventors: Jing Zhou, Laiyong You, Jiani Liang, Lingli Zhou, Mengli Liu, Ruiyun Tian
  • Publication number: 20240366577
    Abstract: An anti-angiogenic composition is disclosed. The anti-angiogenic composition includes a multi-tyrosine kinase inhibitor having a chemical structure: where the tyrosine kinase inhibitor has a crystalline structure having a single crystal polymorph. The anti-angiogenic composition including the tyrosine kinase inhibitor, as characterized by powder x-ray diffraction, has diffraction peaks at 2? of 11.37 150 18.04 242 288 and 24.72. The tyrosine kinase inhibitor may have a particle size of from about 50 to about 300 microns. The tyrosine kinase inhibitor is injectable. The tyrosine kinase inhibitor has an anti-angiogenic efficacy as indicated by a reduction in endothelial cell marker cd31, vascular endothelial-cadherin (VE-CDH), smooth muscle pericyte marker alpha smooth muscle actin (ASMACT), or a combination thereof, as compared to a control composition.
    Type: Application
    Filed: September 2, 2022
    Publication date: November 7, 2024
    Inventors: Joshua DOLOFF, Victoria LAI, Sarah Yoseph NESHAT, Elia DUH, James Joseph PITINGOLO, Amanda Isabella RAKOSKI, Lingli ZHOU, Haining LU
  • Publication number: 20230346777
    Abstract: The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of ophthalmologic diseases, including non-proliferative diabetic retinopathy (NPDR), diabetic macular edema (DME), retinal ganglion cell/photoreceptor neurodegeneration and cataract.
    Type: Application
    Filed: April 14, 2023
    Publication date: November 2, 2023
    Inventors: William Ernst SCHUBERT, Khaled NASSAR, Peter SANDNER, Carsten TERJUNG, Elia DUH, Hongkwan CHO, Zhenhua XU, Lijuan WU, Lingli ZHOU
  • Publication number: 20220241273
    Abstract: The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of ophthalmologic diseases, including non-proliferative diabetic retinopathy (NPDR), diabetic macular edema (DME), retinal ganglion cell/photoreceptor neurodegeneration and cataract.
    Type: Application
    Filed: February 8, 2022
    Publication date: August 4, 2022
    Inventors: William Ernst SCHUBERT, Khaled NASSAR, Peter SANDNER, Carsten TERJUNG, Elia DUH, Hongkwan CHO, Zhenhua XU, Lijuan WU, Lingli ZHOU
  • Publication number: 20210353710
    Abstract: In one aspect, GLP-1r agonists including long-acting PEGylated exenatide (NLY01), exenatide, liraglutide, exenatide LAR (long acting), taspoglutide, albiglutide, dulaglutide, lixisenatide, semaglutide, LY2189265 are used to treat ocular ischemic, inflammatory, angiogenic, and/or degenerative conditions.
    Type: Application
    Filed: March 5, 2021
    Publication date: November 18, 2021
    Inventors: Elia Duh, Zhenhua Xu, Lingli Zhou, Seulki Lee, Yumin Oh
  • Patent number: 9915571
    Abstract: The present invention relates to the field of radio frequency identification, in particular to a temperature measurement and calibration circuit and a passive radio frequency identification tag. Meanwhile, the present invention further relates to a method for performing temperature measurement by using the tag. The temperature measurement and calibration circuit of the tag generates an upper reference voltage value limit and a lower reference voltage value limit, which do not change with temperature, then calibrates the upper reference voltage value limit and the lower reference voltage value limit to a uniform upper voltage value limit and a uniform lower voltage value limit, and eliminates the problem of different reference voltages of tags due to the power supply voltage fluctuation and process deviation. Meanwhile, a temperature measurement voltage generator circuit of the tag generates a calibration voltage value under a uniform calibration temperature.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: March 13, 2018
    Inventors: Patrick Bian Wu, Xingyi Wang, Lingli Zhou, Fuqiang Han, Shehu Qi, Yuanming Luo
  • Publication number: 20160078535
    Abstract: The application relates to systems and methods for managing funds. The system is programmed to receive an instruction about a first exchange-traded fund (ETF) in a first exchange system, identify a second ETF according to the instruction in a second exchange system, determine a first underlying currency for the first ETF and a second underlying currency for the second ETF and a currency exchange rate between the first underlying currency and the second underlying currency, obtain an exchange ratio between the first ETF and the second ETF based on the currency exchange rate and components of the first and second ETFs, and exchange a first number of shares of the first ETF to a second number of shares of the second ETF according to the exchange ratio. Thus, the systems and methods allow investors to exchange shares of one ETF to those of another ETF instantly.
    Type: Application
    Filed: September 12, 2014
    Publication date: March 17, 2016
    Applicant: CSOP ASSET MANAGEMENT LIMITED
    Inventors: Chen DING, Yiding WANG, Lingli ZHOU, Yan LU, Guoyan ZHANG
  • Publication number: 20150268103
    Abstract: The present invention relates to the field of radio frequency identification, in particular to a temperature measurement and calibration circuit and a passive radio frequency identification tag. Meanwhile, the present invention further relates to a method for performing temperature measurement by using the tag. The temperature measurement and calibration circuit of the tag generates an upper reference voltage value limit and a lower reference voltage value limit, which do not change with temperature, then calibrates the upper reference voltage value limit and the lower reference voltage value limit to a uniform upper voltage value limit and a uniform lower voltage value limit, and eliminates the problem of different reference voltages of tags due to the power supply voltage fluctuation and process deviation. Meanwhile, a temperature measurement voltage generator circuit of the tag generates a calibration voltage value under a uniform calibration temperature.
    Type: Application
    Filed: March 18, 2015
    Publication date: September 24, 2015
    Inventors: Patrick Bian Wu, Xingyi Wang, Lingli Zhou, Fuqiang Han, Shehu Qi, Yuanming Luo